Emerging Infectious Diseases (Oct 2020)

COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

  • François Bénézit,
  • Audrey Le Bot,
  • Stéphane Jouneau,
  • Florian Lemaître,
  • Charlotte Pronier,
  • Pierre-Axel Lentz,
  • Solène Patrat-Delon,
  • Matthieu Revest,
  • Vincent Thibault,
  • Pierre Tattevin

DOI
https://doi.org/10.3201/eid2610.201816
Journal volume & issue
Vol. 26, no. 10
pp. 2513 – 2515

Abstract

Read online

Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.

Keywords